Doctor profile · Federal record

Dr. Himara Davila Arroyo, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Houston, TX

  • NPI 1720390065
  • Accepts Medicare
  • MIPS 83.1 / 100 · 2023
  • 21 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
13333 Dotson RD, Suite 220
Houston, TX 77070
(281) 251-5234
fax (281) 251-7868
Mailing address
10815 Painted Crescent CT
Cypress, TX 77433

Credentials & registration

NPPES · NUCC
NPI registered
July 2010 — 16 yrs on file
Profile last updated
April 8, 2026
Year of graduation
2005 — 21 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
Texas #N6248

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1720390065. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
456
Distinct HCPCS
7
Medicare allowed
$47,529
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 168 93 $122
99215 Established patient office or other outpatient visit, 40-54 minutes 129 62 $164
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 51 22 $31
83036 Hemoglobin a1c level 37 24 $9
82947 Blood glucose (sugar) level 28 21 $3
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 27 15 $51
99204 New patient office or other outpatient visit, 45-59 minutes 16 16 $159

In context: peer comparison

Among 59 peers in this city , average services per provider: 198. This provider delivers 2.3× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,890
Transactions
156
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Insulet Corporation 39 $328.21
Bayer Healthcare Pharmaceuticals Inc. 11 $255.86
Lilly USA, LLC 14 $221.10
Corcept Therapeutics 13 $201.45
SANOFI-AVENTIS U.S. LLC 13 $193.66
Novo Nordisk Inc 16 $187.20
Boehringer Ingelheim Pharmaceuticals, Inc. 8 $183.77
Astellas Pharma US Inc 9 $162.31
Amgen Inc. 10 $150.34
ABBVIE INC. 5 $98.88
Esperion Therapeutics, Inc. 5 $89.50
BETA BIONICS, INC. 4 $80.25
Novartis Pharmaceuticals Corporation 3 $71.24
Amphastar Pharmaceuticals, Inc. 3 $63.84
IBSA Pharma Inc. 3 $63.10

By nature of payment

Food and Beverage
$2,879
Education
$11

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,977
Patients
658
Total drug cost
$1,500,995
Drug Type Claims Patients Total cost
Ozempic (Semaglutide) Brand 381 108 $762,368
Levothyroxine Sodium Generic 263 83 $3,860
Rosuvastatin Calcium Generic 183 72 $8,033
Synjardy Xr (Empagliflozin/Metformin Hcl) Brand 178 54 $259,728
Synthroid (Levothyroxine Sodium) Brand 119 43 $12,649
Lisinopril Generic 117 36 $983
Atorvastatin Calcium Generic 103 38 $2,183
Liothyronine Sodium Generic 96 29 $4,690
Metformin Hcl Er (Metformin Hcl) Brand 96 39 $2,716
Trulicity (Dulaglutide) Brand 94 27 $187,446

Frequently asked questions

Auto-generated from federal data
What is Dr. Himara Davila Arroyo's medical specialty?
Dr. Himara Davila Arroyo practices Endocrinology, Diabetes & Metabolism Physician in Houston, TX.
Where does Dr. Himara Davila Arroyo practice?
Dr. Himara Davila Arroyo practices at 13333 Dotson RD, Suite 220, Houston, TX 77070. Office phone: 2812515234.
What is Dr. Himara Davila Arroyo's NPI?
Dr. Himara Davila Arroyo's National Provider Identifier (NPI) is 1720390065, issued by NPPES.
Does Dr. Himara Davila Arroyo accept Medicare assignment?
Yes. Dr. Himara Davila Arroyo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Himara Davila Arroyo commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.